“Although the rates of appearance of these resistant organisms is low, and comparable to standard-of-care antibiotics, the observation affirms the principle that we can never rest on our laurels ...

Since macrolides are bacteriostatic antibiotics, the eradication of Chlamydia strains and other intracellular bacteria is unlikely, and the beneficial effects are only minor and transient.